Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union

The European Union is opting to buy 100 million additional doses of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) BNT162b2 vaccine, the two companies announced in a joint press release. This adds to the original 200 million dose order from the EU, a political and economic bloc of 27 countries on that continent.